ecrin-mdr-crcClinical2018Metastatic Colorectal CancerColorectal NeoplasmsMetastatic Colorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2261846China1IrinotecanBevacizumabECRIN MDRWithdrawnfalsePhase I Study of Biweekly SIRB Regimen for Metastatic Colorectal CancerPhase I Study of biweekly combination therapy with S-1, Irinotecan, and Bevacizumab as 1-line Chemotherapy in Patients With Advanced Colorectal Cancer.2018-01-152261846NCT03380689